MedPath

PredAID-CERVIA: AI based Cervical Cancer Screening

Not Applicable
Registration Number
CTRI/2022/05/042719
Lead Sponsor
BlockAppsAI Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Women aged between 25 and 65 years of age, inclusive.

2)Participants should have a history of sexual activity.

Exclusion Criteria

1)Menstruating women

2)Pregnant women women who have had childbirth with 6 weeks prior to the date of test

3)Women who have had hysterectomy

4)Women who have vaginal infections, discharge etc. at the time of the test

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Specificity, sensitivity, PPV and NPV of prediction of VIA classes, namely, Positive, Negative or Suspicious for Cancer by PredAID-CerVIA and a group of experienced gynecologists (Human Expert Group), taking a combination of conventional cytology (Pap smear) and physicians verdict as reference.Timepoint: 9 Months
Secondary Outcome Measures
NameTimeMethod
Secondary outcome: Measure of the subjects experience, and opinion of the VIA procedure based on the following criteria â?? level of comfort, level of comfort with smartphone camera-based image acquisition the likelihood of repeating the test on a yearly two-yearly or five-yearly basisTimepoint: Same time point as the primary outcome
© Copyright 2025. All Rights Reserved by MedPath